메뉴 건너뛰기




Volumn 358, Issue 9282, 2001, Pages 605-613

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction

(857)  Van de Werf, F a   Armstrong, P W a   Granger, C a   Wallentin, L a   Adgey, A A J a   Aylward, P a   Binbrek, A S a   Califf, R a   Cassim, S a   Diaz, R a   Fanebust, R a   Fioretti, P M a   Huber, K a   Husted, S a   Lindahl, B a   Lopez Sendon J L a   Makijarvi M a   Meyer, J a   Navarro Robles, J a   Pfisterer, M a   more..


Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; PYRIDINE DERIVATIVE; STATIN; TENECTEPLASE; THIENOPYRIDINE; TICLOPIDINE; UNCLASSIFIED DRUG;

EID: 0035949117     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05775-0     Document Type: Article
Times cited : (803)

References (14)
  • 1
    • 0033612881 scopus 로고    scopus 로고
    • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
    • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial.
    • (1999) Lancet , vol.354 , pp. 716-722
  • 3
    • 0035849537 scopus 로고    scopus 로고
    • Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion, part I
    • Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion, part I.
    • (2001) Circulation , vol.103 , pp. 2865-2866
    • Armstrong, P.W.1    Collen, D.2
  • 4
    • 0034917336 scopus 로고    scopus 로고
    • Low molecular weight heparins in the treatment of acute coronary syndromes
    • Low molecular weight heparins in the treatment of acute coronary syndromes.
    • (2001) Arch Intern Med , vol.161 , pp. 1484-1490
    • Turpie, A.G.G.1    Antman, E.M.2
  • 5
    • 0035822605 scopus 로고    scopus 로고
    • A randomized comparison of low-molecular-weight heparin enoxaparin and unfractionated heparin adjunctive to t-PA thrombolysis and aspirin (HART II)
    • A randomized comparison of low-molecular-weight heparin enoxaparin and unfractionated heparin adjunctive to t-PA thrombolysis and aspirin (HART II).
    • (2001) Circulation , vol.104 , pp. 648-652
    • Ross, A.M.1    Molhoek, P.2    Lundergan, C.3
  • 6
    • 0008832293 scopus 로고    scopus 로고
    • Early ST segment elevation resolution: Predictor of outcome and angiographic patency in patients with acute myocardial infarction. Results of the AMI-SK study
    • in press
    • Early ST segment elevation resolution: Predictor of outcome and angiographic patency in patients with acute myocardial infarction. Results of the AMI-SK study.
    • Eur Heart J
    • Simoons, M.L.1    Alonso, A.2    Krzeminska-Pakula, M.3
  • 8
    • 0035115802 scopus 로고    scopus 로고
    • The low-molecular-10 weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT Plus study
    • The low-molecular-10 weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT Plus study.
    • (2001) Clin Cardiol , vol.24 , Issue.SUPPL. 3
    • Wallentin, L.1    Dellborg, D.M.2    Lindahl, B.3
  • 9
    • 0033152273 scopus 로고    scopus 로고
    • Abciximab facilitates the rate and extent of thrombolysis: Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial
    • Abciximab facilitates the rate and extent of thrombolysis: Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial.
    • (1999) Circulation , vol.99 , pp. 2720-2732
    • Antman, E.M.1    Giugliano, R.P.2    Gibson, C.M.3
  • 10
    • 0343798542 scopus 로고    scopus 로고
    • Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction
    • Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction.
    • (2000) Circulation , vol.101 , pp. 2788-2794
  • 11
    • 0000777970 scopus 로고    scopus 로고
    • INTRO AMI: Marked enhancement of arterial patency with eptifibatide and low-dose t-PA in acute myocardial infarction
    • abstr
    • INTRO AMI: Marked enhancement of arterial patency with eptifibatide and low-dose t-PA in acute myocardial infarction.
    • (1999) Circulation , vol.100 , Issue.SUPPL.
    • Brener, S.J.1    Vrobel, T.R.2    Lopez, J.F.3
  • 12
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial.
    • (2001) Lancet , vol.357 , pp. 1905-1914
  • 13
    • 0033621148 scopus 로고    scopus 로고
    • 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
    • 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
    • (1999) Circulation , vol.100 , pp. 1016-1030
    • Ryan, T.J.1    Antman, E.M.2    Brooks, N.H.3
  • 14
    • 0035033834 scopus 로고    scopus 로고
    • Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial haemorrhage
    • Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial haemorrhage.
    • (2001) Am Heart J , vol.141 , pp. 742-750
    • Giugliano, R.P.1    McCabe, C.H.2    Antman, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.